Inflammation after stroke: Is it harmful?

Archives of Neurology

Volumn 58, Issue 4, 2001, Pages 669-672

  Del Zoppo, G J ^a   Becker, K J ^a   Hallenbeck, J M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1BETA; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

BRAIN INJURY; BRAIN ISCHEMIA; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STROKE; THROMBOSIS;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ENCEPHALITIS; HUMANS; ISCHEMIC PRECONDITIONING; THROMBOSIS;

EID: 0035067971     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons
2. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat)
3. P selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion
4. E selectin appears in non-ischemic tissue during experimental focal cerebral ischemia
5. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons
6. 3 is expressed in selected microvessels following focal cerebral ischemia
7. 3 during focal cerebral ischemia
8. Production of tumor necrosis factor-alpha and interleukin-1 beta by human cerebral microvascular endothelium after percussive trauma
9. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization
10. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat
11. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
12. Inflammatory mediators and stroke: New opportunities for novel therapeutics
13. Biologic basis for interleukin-1 in disease
14. Tumor necrosis factor-alpha expression in ischemic neurons
15. Intracerebral administration of interleukin-1 beta and induction of inflammation, apoptosis, and vasogenic edema
16. Neuronal death in cytokine-activated primary human brain cell culture: Role of tumor necrosis factor-alpha
17. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal ischemia in the rat
18. Peripheral administration of interleukin receptor antagonist-1 inhibits brain damage after focal cerebral ischemia in the rat
19. Inflammatory reactions at the blood-endothelial interface in acute stroke
20. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells
21. 2 after transient global forebrain ischemia in the rat
22. LTC4/LTB4 alterations in rat forebrain ischemia and reperfusion and effects of AA-861, CV-3988
23. Brain eicosanoid levels during temporary focal cerebral ischemia in rats: A microdialysis study
24. Platelet-activating factor in brain regions after transient ischemia in gerbils
25. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression
26. Tissue factor contributes to microvascular defects following cerebral ischemia
27. Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity
28. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
29. "Ischemic tolerance" phenomenon found in the brain
30. Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons
31. Ischemic "cross" tolerance in hypoxic ischemia of immature rat brain
32. Ischemic tolerance in the brain
33. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons
34. Lipopolysaccharide pretreatment induces resistance against subsequent focal ischemic damage in spontaneously hypertensive rats
35. TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice
36. Neuroprotective effects of TGF-β1
37. Transforming growth factor-beta: An important mediator of immuno regulation
38. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: Changes induced by focal cerebral ischemia
39. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated
40. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression
41. Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model
42. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia: Dose-response relationship and potential neuroprotective mechanisms
43. Experimental antileukocyte interventions in cerebral ischemia
44. Inflammatory responses in cerebral ischemia: Role of leukocytes
45. 3 inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia
46. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: Effects of neutrophil depletion
47. Postischemic administration of an anti-MAC-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats
48. Anti-ICAM-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wister rat
49. Exacerbation of cerebral injury in mice that express the P-selectin gene: Identification of P-selectin blockade as a new target for the treatment of stroke
50. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury
51. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidate
52. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
53. Dual role of tumor necrosis factor alpha in brain injury
54. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
55. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
56. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes
57. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression
58. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
59. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage
60. Induction of cyclooxygenase-2 in the rat brain after a mild episode of focal ischemia without tissue inflammation or neural cell damage
61. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia
62. Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats
63. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs
64. Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats
65. The Enlimomab Acute Stroke Trial: Final results (abstract and presentation) in 49th Annual Meeting of the American Academy of Neurology
66. Some potentially harmful side effects of anti-ICAM-1 antibody administration in preclinical animal studies of stroke
67. Stroke therapy: It may be time for an integrated approach